Activity of Imipenem-Relebactam against Pseudomonas aeruginosa with Antimicrobial-Resistant Phenotypes from Seven Global Regions—SMART 2015-2016

ConclusionsImipenem-relebactam could provide an important treatment option against infections with P. aeruginosa isolates that are not susceptible to several currently available antipseudomonal β-lactams.

Source: Journal of Global Antimicrobial Resistance - July 30, 2018 Category: Infectious Diseases Source Type: research